André J Scheen (André Scheen, Andre Scheen)

Publication Activity (10 Years)

Years Active: 2017-2024
Publications (10 Years): 10

Top Topics

Cardiovascular Risk Factors

Glycemic Control

Top Venues

Revue medicale suisse

Diabetes, obesity & metabolism

Diabetes, metabolic syndrome and obesity : targets and therapy

Expert review of clinical pharmacology

This page only lists publications with an associated author ORCID identifier.

Publications

André J Scheen, Nicolas Paquot
[Innovative therapeutic drug combination for type 2 diabetes at cardiorenal risk]. Revue medicale suisse 20 (884) (2024)
André J Scheen
[Underuse of SGLT2 inhibitors in clinical practice]. Revue medicale suisse 20 (884) (2024)
André J Scheen
Bridging the gap in cardiovascular care in diabetic patients: are cardioprotective antihyperglycemic agents underutilized? Expert review of clinical pharmacology (2023)
André J Scheen
[Effects of antidiabetic medications on metabolic-associated fatty liver disease]. Revue medicale suisse 19 (838) (2023)
André J Scheen
Pharmacokinetic, toxicological and clinical considerations for the treatment of type 2 diabetes in patients with liver disease: a comprehensive update. Expert opinion on drug metabolism & toxicology (2023)
Yawa Abouleka, Kamel Mohammedi, Charlyne Carpentier, Severine Dubois, Pierre Gourdy, Jean-François Gautier, Ronan Roussel, André J Scheen, François Alhenc-Gelas, Samy Hadjadj, Gilberto Velho, Michel Marre
ACE I/D Polymorphism, Plasma ACE Levels, and Long-term Kidney Outcomes or All-Cause Death in Patients With Type 1 Diabetes. Diabetes care 44 (6) (2021)
André J Scheen
SGLT2 Inhibitors as Add-On Therapy to Metformin for People with Type 2 Diabetes: A Review of Placebo-Controlled Trials in Asian versus Non-Asian Patients. Diabetes, metabolic syndrome and obesity : targets and therapy 13 (2020)
André J Scheen
Sodium-glucose cotransporter type 2 inhibitors for the treatment of type 2 diabetes mellitus. Nature reviews. Endocrinology 16 (10) (2020)
Serge A Jabbour, Jochen Seufert, André J Scheen, Clifford J Bailey, Cathrina Karup, Anna M Langkilde
Dapagliflozin in patients with type 2 diabetes mellitus: A pooled analysis of safety data from phase IIb/III clinical trials. Diabetes, obesity & metabolism 20 (3) (2017)
Fabrice Bonnet, André J Scheen
Understanding and overcoming metformin gastrointestinal intolerance. Diabetes, obesity & metabolism 19 (4) (2017)